Finerenone use in CKD and T2D: from clinical trials to the clinic.
Topic:
Clinical
Sponsored by Bayer
Event:
ESC Congress 2022
Congress Presentation
About the speakers
Doctor Pam Taub
University of California San Diego, San Diego (United States of America)
5
presentations
0
follower
Professor George Bakris
University of Chicago Medicine, Chicago (United States of America)
6
presentations
2
followers
4 more presentations in this session
Welcome and introductions.
Speaker: Professor G. Filippatos (Athens, GR) Professor G. Bakris (Chicago, US)
Cardiovascular protection in patients with chronic kidney disease (CKD) and T2D: time for a new approach?
Speaker: Professor J. Bauersachs (Hannover, DE)
Finerenone in cardiovascular care: exploring a new treatment pathway.
Speaker: Professor A. Voors (Groningen, NL)
Access the full session
Cardiorenal benefits of finerenone: protecting the heart and kidneys
Speakers:
Doctor P. Taub, Professor G. Bakris, Professor G. Filippatos, Professor G. Bakris, Professor J. Bauersachs...
About the event
ESC 365 is supported by
